Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Terpinolene is a monoterpene found in various plants, including *Cannabis sativa*, nutmeg, and cumin, known for its fresh, piney, and herbal aroma. Recent research presented at the ATS 2025 conference highlights its potential as a bronchodilator for the treatment of obstructive airway diseases such as asthma. Terpinolene works by relaxing airway smooth muscle (ASM) through the inhibition of contractile agonist-induced phosphorylation of myosin light chain 20 (pMLC20). Additionally, it demonstrates a synergistic effect when used in combination with beta-2 adrenergic receptor (B2AR) agonists like isoproterenol, significantly potentiating their muscle-relaxing properties. This dual action suggests that terpinolene could serve as a novel therapeutic component or adjunct in respiratory care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on terpinolene.